Executive Summary
Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral by-products in Russia, European Union, the Commonwealth of Independent States, the United States, Canada, Latin America, the People’s Republic of China, rest of Asia, and other regions.
Snowflake
Fundamentals
Outstanding track record average dividend payer.
Similar Companies
Share Price & News
How has Acron's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: AKRN has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
-1.3%
AKRN
-0.6%
RU Chemicals
-1.9%
RU Market
1 Year Return
5.3%
AKRN
11.8%
RU Chemicals
20.6%
RU Market
Return vs Industry: AKRN underperformed the Russian Chemicals industry which returned 11.8% over the past year.
Return vs Market: AKRN underperformed the Russian Market which returned 20.6% over the past year.
Shareholder returns
| AKRN | Industry | Market | |
|---|---|---|---|
| 7 Day | -1.3% | -0.6% | -1.9% |
| 30 Day | -3.0% | -2.2% | 4.6% |
| 90 Day | 2.7% | 4.8% | 8.9% |
| 1 Year | 11.5%5.3% | 22.5%11.8% | 29.4%20.6% |
| 3 Year | 82.6%44.7% | 34.0%14.6% | 63.2%37.7% |
| 5 Year | 401.6%240.2% | 156.9%106.4% | 152.5%98.1% |
Price Volatility Vs. Market
How volatile is Acron's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall St
Should We Worry About Public Joint Stock Company Acron's (MCX:AKRN) P/E Ratio?11 months ago | Simply Wall St
What Should You Know About Public Joint Stock Company Acron's (MCX:AKRN) Return On Capital?1 year ago | Simply Wall St
Is Public Joint Stock Company Acron's (MCX:AKRN) 22% ROE Strong Compared To Its Industry?Valuation
Is Acron undervalued compared to its fair value and its price relative to the market?
7.25x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: AKRN (RUB4878) is trading above our estimate of fair value (RUB3615.22)
Significantly Below Fair Value: AKRN is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: AKRN is poor value based on its PE Ratio (7.2x) compared to the Chemicals industry average (5.2x).
PE vs Market: AKRN is good value based on its PE Ratio (7.2x) compared to the Russian market (7.4x).
Price to Earnings Growth Ratio
PEG Ratio: AKRN is poor value based on its PEG Ratio (2.6x)
Price to Book Ratio
PB vs Industry: AKRN is overvalued based on its PB Ratio (3x) compared to the RU Chemicals industry average (1.5x).
Next Steps
Future Growth
How is Acron forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?
2.8%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AKRN's forecast earnings growth (2.8% per year) is below the savings rate (8.4%).
Earnings vs Market: AKRN's earnings (2.8% per year) are forecast to grow slower than the Russian market (4.6% per year).
High Growth Earnings: AKRN's earnings are forecast to grow, but not significantly.
Revenue vs Market: AKRN's revenue (8.4% per year) is forecast to grow faster than the Russian market (4.3% per year).
High Growth Revenue: AKRN's revenue (8.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AKRN's Return on Equity is forecast to be high in 3 years time (29.5%)
Next Steps
Past Performance
How has Acron performed over the past 5 years?
6.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: AKRN has high quality earnings.
Growing Profit Margin: AKRN's current net profit margins (22.2%) are higher than last year (15.4%).
Past Earnings Growth Analysis
Earnings Trend: AKRN's earnings have grown by 6.9% per year over the past 5 years.
Accelerating Growth: AKRN's earnings growth over the past year (76.6%) exceeds its 5-year average (6.9% per year).
Earnings vs Industry: AKRN earnings growth over the past year (76.6%) exceeded the Chemicals industry 73.8%.
Return on Equity
High ROE: AKRN's Return on Equity (32.3%) is considered high.
Return on Assets
Return on Capital Employed
Next Steps
Financial Health
How is Acron's financial position?
Financial Position Analysis
Short Term Liabilities: AKRN's short term assets (RUB42.4B) exceeds its short term liabilities (RUB33.9B)
Long Term Liabilities: AKRN's short term assets (RUB42.4B) do not cover its long term liabilities (78.7B)
Debt to Equity History and Analysis
Debt Level: AKRN's debt to equity ratio (95.6%) is considered high.
Reducing Debt: AKRN's debt to equity ratio has increased from 67.9% to 95.6% over the past 5 years.
Debt Coverage: AKRN's debt is well covered by operating cash flow (38.4%).
Interest Coverage: AKRN's interest payments on its debt are well covered by EBIT (20.1x coverage).
Balance Sheet
Inventory Level: AKRN has a high level of physical assets or inventory.
Debt Coverage by Assets: AKRN's debt is not covered by short term assets (assets are 0.5x debt).
Next Steps
Dividend
What is Acron's current dividend yield, its reliability and sustainability?
3.59%
Current Dividend Yield
Upcoming Dividend Payment
Purchase Acron before the 'Buy Limit' to receive their next dividend payment.
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: AKRN's dividend (3.59%) is higher than the bottom 25% of dividend payers in the Russian market (3.57%).
High Dividend: AKRN's dividend (3.59%) is low compared to the top 25% of dividend payers in the Russian market (8.88%).
Stability and Growth of Payments
Stable Dividend: AKRN's dividend payments have been volatile in the past 10 years.
Growing Dividend: AKRN's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its low payout ratio (20.1%), AKRN's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: AKRN's dividends in 3 years are forecast to be covered by earnings (53.3% payout ratio).
Next Steps
Management
What is the CEO of Acron's salary, the management and board of directors tenure and is there insider trading?
8.1yrs
Average management tenure
CEO
Vladimir Kunitsky (71yo)
8.8yrs
Tenure
Mr. Vladimir Ya. Kunitsky has been the Chairman of the Managing Board and Chief Executive Officer of Public Joint Stock Company Acron since 2011 and has been its Member of the Managing Board since 2005. Mr ...
Management Age and Tenure
8.1yrs
Average Tenure
54.5yo
Average Age
Experienced Management: AKRN's management team is seasoned and experienced (8.1 years average tenure).
Board Age and Tenure
4.3yrs
Average Tenure
59yo
Average Age
Experienced Board: AKRN's board of directors are considered experienced (4.3 years average tenure).
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Management Team
Alexander Popov (50yo)
Chairman & Senior VP
- Tenure: 4.3yrs
Vladimir Kunitsky (71yo)
Chairman of the Management Board & CEO
- Tenure: 8.8yrs
Vladimir Gavrikov (59yo)
Deputy Chairman of the Board
- Tenure: 4.3yrs
Alexander Dynkin (71yo)
CEO Advisor & Director
- Tenure: 11.8yrs
Alexei Milenkov (46yo)
Finance Director & Member of the Managing Board
- Tenure: 9.6yrs
Ilya K. Popov
Head of Investor Relations
- Tenure: 0yrs
Dmitry Khabrat (49yo)
VP of Overseas & Member of the Managing Board
- Tenure: 7.3yrs
Irina Raber (70yo)
VP of Human Resources & Special Projects and Member of the Managing Board
- Tenure: 5.8yrs
Dmitry Balandin (39yo)
VP of Finance & Economics and Member of the Managing Board
- Tenure: 0.9yrs
Alexander Lebedev
VP of Domestic Business & Agricultural Projects and Member of the Managing Board
- Tenure: 0.9yrs
Board Members
Alexander Popov (50yo)
Chairman & Senior VP
- Tenure: 4.3yrs
Nikolai Arutyunov (55yo)
Senior Independent Director
- Tenure: 3.5yrs
Vladimir Gavrikov (59yo)
Deputy Chairman of the Board
- Tenure: 4.3yrs
Alexander Dynkin (71yo)
CEO Advisor & Director
- Tenure: 11.8yrs
Yury Malyshev (80yo)
Independent Director
- Tenure: 4.5yrs
Vladimir Sister (74yo)
Independent Director
- Tenure: 4.5yrs
Georgy Golukhov (59yo)
CEO Advisor & Director
- Tenure: 3.5yrs
Company Information
Public Joint Stock Company Acron's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Public Joint Stock Company Acron
- Ticker: AKRN
- Exchange: MISX
- Founded: 1992
- Industry: Fertilizers and Agricultural Chemicals
- Sector: Materials
- Market Cap: ₽190.723b
- Shares outstanding: 39.10m
- Website: https://www.acron.ru
Location
- Public Joint Stock Company Acron
- World Trade Centre
- 12 Krasnopresnenskaya Naberezhnaya
- Moscow
- 123610
- Russia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| AKRN | MISX (Micex - Rts) | Yes | Ordinary Shares | RU | RUB | Jan 1996 |
| AKRN | LSE (London Stock Exchange) | GDR EACH REPR 0.1 SH 'REGS' | GB | USD | Aug 2008 | |
| AKRNL | BATS-CHIXE (BATS 'Chi-X Europe') | GDR EACH REPR 0.1 SH 'REGS' | GB | USD | Aug 2008 |
Biography
Public Joint Stock Company Acron, together with its subsidiaries, manufactures, distributes, and sells chemical fertilizers and related mineral by-products in Russia, European Union, the Commonwealth of In ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/11/18 21:21 |
| End of Day Share Price | 2019/11/18 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.